• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

AZ only company going back to “normal”





And you base this on what, an assumption? Do you know how many times people like you have predicted a lay-off, early retirement, severance packages. I don’t know what divisions you are talking about, but in oncology we will be expanding next year, we are filling open territories, promotions, and launches on a continuous bases. So who is going to sell and call on doctor’s when we expand our new indications, a commercial, social media, no my friend, the sales rep, especially in oncology when we have to meet these doctors, nurses, and staff face to face.